How has EGFR testing changed the way we treat non–small cell lung cancer? In this AJMC Peer Exchange episode, panelists discuss how identifying key EGFR mutations has enabled more precise therapy selection, improved outcomes, and reduced toxicity compared with chemotherapy. The conversation also highlights the shift toward targeted, chemotherapy-free regimens across early and later lines of treatment. Watch the full episode: https://hubs.li/Q03_bknk0 #NSCLC #PrecisionOncology #LungCancer | The A

Upfront EGFR Therapy in Metastatic Colorectal Cancer | OncLive

Personalized Treatment in mCRC: Molecular Profiling and Anti-EGFR Therapy

Navigating EGFR Pathway in Colorectal Cancer | OncLive

Interaction of the EGF Receptor and the Hippo Pathway in the Diabetic Kidney.

EGFR Inhibitor-Linked Cytokine Storms: Study Uncovers the Trigger | Newswise